BioLife Solutions, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
BioLife Solutions, Inc. (BLFS) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$78.19 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-11
- BioLife Solutions, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$41.03K.
- BioLife Solutions, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$37.15K, a 103.47% decline year-over-year.
- BioLife Solutions, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$269.64K, a 132.75% decline year-over-year.
- BioLife Solutions, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$193.17K.
- BioLife Solutions, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $392.79K, a 90.74% decline from fiscal 2015.
- BioLife Solutions, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $4.24M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$41.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$78.19K 10-Q · filed 2017-08-11 | -$347.82K derived: sum of 3 quarters · filed 2017-08-11 | -$541.00K derived: sum of 4 quarters · filed 2017-08-11 |
| 2017-03-31 | -$37.15K 10-Q · filed 2017-05-12 | -$306.79K derived: sum of 2 quarters · filed 2017-05-12 | -$499.96K derived: sum of 3 quarters · filed 2017-05-12 | -$714.89K derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-12-31 | -$269.64K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$462.81K derived: sum of 2 quarters · filed 2017-03-15 | -$677.74K derived: sum of 3 quarters · filed 2017-08-11 | $392.79K 10-K · filed 2017-03-15 |
| 2016-09-30 | -$193.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$408.10K derived: sum of 2 quarters · filed 2017-08-11 | $662.43K 10-Q · filed 2016-11-10 | $1.49M derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-06-30 | -$214.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $855.60K 10-Q · filed 2017-08-11 | $1.68M derived: sum of 3 quarters · filed 2017-08-11 | $1.28M derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-03-31 | $1.07M 10-Q · filed 2017-05-12 | $1.89M derived: sum of 2 quarters · filed 2017-05-12 | $1.50M derived: sum of 3 quarters · filed 2017-05-12 | $3.59M derived: sum of 4 quarters · filed 2017-05-12 |
| 2015-12-31 | $823.22K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $426.97K derived: sum of 2 quarters · filed 2017-03-15 | $2.52M derived: sum of 3 quarters · filed 2017-03-15 | $4.24M 10-K · filed 2017-03-15 |
| 2015-09-30 | -$396.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $1.70M derived: sum of 2 quarters · filed 2016-11-10 | $3.42M 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $3.81M 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | $1.72M 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |